Ewg Elevate Inc. Adma Biologics, Inc. Transaction History

Ewg Elevate Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$5.98 - $11.18 $179,400 - $335,400	-30,000 Reduced 30.0%	70,000 $782,000
Q1 2024 Apr 09, 2024	BUY	$4.4 - $6.74 $220,000 - $337,000	50,000 Added 100.0%	100,000 $660,000
Q4 2023 Jan 08, 2024	BUY	$3.08 - $4.52 $77,000 - $112,999	25,000 Added 100.0%	50,000 $225,000
Q3 2023 Oct 10, 2023	SELL	$3.47 - $4.61 $135,330 - $179,790	-39,000 Reduced 60.94%	25,000 $89,000
Q2 2023 Jul 12, 2023	SELL	$3.12 - $4.22 $112,320 - $151,920	-36,000 Reduced 36.0%	64,000 $236,000
Q1 2023 Apr 13, 2023	BUY	$3.01 - $3.87 $301,000 - $387,000	100,000 New	100,000 $331,000
Q3 2022 Oct 13, 2022	BUY	$2.03 - $2.86 $42,629 - $60,060	21,000 Added 21.0%	121,000 $294,000
Q1 2022 Apr 12, 2022	BUY	$1.28 - $1.83 $128,000 - $183,000	100,000 New	100,000 $183,000

319

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.85B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Ewg Elevate Inc., based on Form 13F filings with the SEC.

Stay updated on Ewg Elevate Inc. with notifications on news.